Verrica Pharmaceuticals Inc. (VRCA) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Verrica Pharmaceuticals Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Verrica Pharmaceuticals Inc.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-18.37%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Positive
CHATGPT
Continuing Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Verrica Pharmaceuticals Inc. actually do?
Answer:
Verrica Pharmaceuticals Inc. is a therapeutics company focused on developing and commercializing treatments for dermatologic diseases, including skin cancers. Its lead commercial product, YCANTH (VP-102), is the first FDA-approved treatment for molluscum contagiosum in adult and pediatric patients, launched in August 2023. The company is also advancing YCANTH (VP-102) for common warts and VP-315, an injectable therapy, for basal cell carcinoma. Verrica operates a specialized sales force of approximately 40 representatives in the United States targeting dermatologists and pediatricians. The company is exploring international partnerships and has secured broad payor coverage for YCANTH in the U.S.
Question:
What are Verrica Pharmaceuticals Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by sales of YCANTH (VP-102) for molluscum contagiosum in the United States. Additional revenue streams include license and collaboration revenue, such as milestone payments from its Japanese partner, Torii.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required